- Home
- HCWB vs ABTS Comparison
HCWB vs ABTS Comparison
Compare HCWB & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- ABTS
- Stock Information
- Founded
- HCWB 2018
- ABTS 2010
- Country
- HCWB United States
- ABTS Hong Kong
- Employees
- HCWB N/A
- ABTS N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- ABTS Computer Software: Programming Data Processing
- Sector
- HCWB Health Care
- ABTS Technology
- Exchange
- HCWB Nasdaq
- ABTS Nasdaq
- Market Cap
- HCWB 10.8M
- ABTS 9.8M
- IPO Year
- HCWB 2021
- ABTS N/A
- Fundamental
- Price
- HCWB $3.45
- ABTS $3.75
- Analyst Decision
- HCWB Strong Buy
- ABTS
- Analyst Count
- HCWB 1
- ABTS 0
- Target Price
- HCWB $35.00
- ABTS N/A
- AVG Volume (30 Days)
- HCWB 30.0K
- ABTS 16.7K
- Earning Date
- HCWB 08-18-2025
- ABTS 08-13-2025
- Dividend Yield
- HCWB N/A
- ABTS N/A
- EPS Growth
- HCWB N/A
- ABTS N/A
- EPS
- HCWB N/A
- ABTS N/A
- Revenue
- HCWB $832,841.00
- ABTS $7,037,156.00
- Revenue This Year
- HCWB $178.36
- ABTS N/A
- Revenue Next Year
- HCWB N/A
- ABTS N/A
- P/E Ratio
- HCWB N/A
- ABTS N/A
- Revenue Growth
- HCWB N/A
- ABTS 31.69
- 52 Week Low
- HCWB $2.77
- ABTS $1.35
- 52 Week High
- HCWB $100.80
- ABTS $14.10
- Technical
- Relative Strength Index (RSI)
- HCWB 31.06
- ABTS 41.21
- Support Level
- HCWB $2.77
- ABTS $3.99
- Resistance Level
- HCWB $4.65
- ABTS $4.24
- Average True Range (ATR)
- HCWB 0.36
- ABTS 0.27
- MACD
- HCWB -0.09
- ABTS -0.02
- Stochastic Oscillator
- HCWB 36.22
- ABTS 0.00
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.